Search - tctmd.com

Displaying 1 - 20 of 94

Sort: Relevancy | Date

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Daily News

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

Yael L. Maxwell

December 09, 2025

News Conference News ESC 2025

DOUBLE-CHOICE: Minimalist Anesthesia for TAVI Comparable to Standard Care

Todd Neale

August 30, 2025

Presentation NY Valves 2025

Early Bioprosthetic Valve Dysfunction Treated With Urgent Redo TAVI: Acurate Neo2 in Sapien 3

Presenter: Thiago Abizaid

June 26, 2025

Presentation NY Valves 2025

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Presenter: Chloe Kharsa

June 26, 2025

News Daily News

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

Todd Neale

June 18, 2025

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Daily News

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Caitlin E. Cox

May 19, 2025

Presentation Miami Valves 2025

Initial Experience with the Acurate Neo2 TAVR in the Dominican Republic

Presenter: Karla Marie Garcia Almonte

January 30, 2025

Presentation Miami Valves 2025

Selected Case of CE Approved TAVR Valve: Acurate Neo2

Presenter: Fábio S. Brito Jr.

January 30, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Conference News PCR London Valves 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2024

Shelley Wood

November 01, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Presenter: Ignacio Amat-Santos

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

Advertisement

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

DOUBLE-CHOICE: Minimalist Anesthesia for TAVI Comparable to Standard Care

Early Bioprosthetic Valve Dysfunction Treated With Urgent Redo TAVI: Acurate Neo2 in Sapien 3

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli

Initial Experience with the Acurate Neo2 TAVR in the Dominican Republic

Selected Case of CE Approved TAVR Valve: Acurate Neo2

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Top Structural Heart News of 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

TCTMD’s Top 10 Most Popular Stories for October 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 928: Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

What’s Going to Be Big at TCT 2024?

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content